Schwartz is a seasoned executive with more than two decades of experience in a range of finance roles at health tech and financial services organizations. She joins Resmed from Illumina, Inc., where ...

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look ...

Joey Jordison ’s family have shared the drummer’s original design of the Slipknot logo.

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a bispecific factor IXa- and factor X-directed antibody indicated for routine ...

Concise market news. Data-driven. Zero fluff.